UMEM Educational Pearls - Toxicology

Title: Nitrous Oxide a dangerous legal High: "Don't Whippet"

Category: Toxicology

Keywords: Nitrous Oxide, Whippit, unregulated psychotropic, inhalant abuse (PubMed Search)

Posted: 12/2/2025 by Kathy Prybys, MD (Updated: 12/3/2025)
Click here to contact Kathy Prybys, MD

  • Nitrous oxide (N2O) aka “laughing gas”, used clinically for its psychotropic properties as an inhalational anesthetic, is one of the most abused inhalants for decades due to its unregulated wide availability and public perception that it is a safe high. Social media trends have popularized use by teens and young adults.
  • Easily purchased online, in groceries stores, gas stations,  smoke and vape shops it is used as a food processing  propellant in steel aerosol containers like whipped cream and available in small canisters marketed as whipped cream chargers called “whippets”.
  • Between January 1, 2014 - Dec 31, 2023, nitrous oxide nearly doubled in exposure rate with a total of 2,322 exposures reported to U.S Poison Centers.  From 2010-2023,  1240 US deaths were reported between the ages of 15-74 attributable to nitrous oxide poisoning.
  • Similar to Ketamine and phencyclidine, nitrous oxide causes antagonism at the NMDA receptor resulting in short lived reversible euphoria and sedation and analgesic effects through the K-opioid receptor.
  • Nitrous oxide fatalities occur primarily due to asphyxiation and oxygen deprivation causing neurologic sequela, hypotension, arrythmias, and death. N2O depresses the sensation of shortness of breath so users may not seek fresh air.
  •  Chronic recreational N2O exposure impedes vitamin B12 function and causes a distinct neurological syndrome manifested by numbness, gait disturbances, loss of coordination, changes in mentation, and loss of bowel and bladder control, and hematologic abnormalities.
  • On June 6, 2025, the FDA issued a public advisory warning consumers not to inhale nitrous oxide products due to potential for severe adverse events if used for recreational nonfood purposes.

Show Additional Information

Show References



Title: Cyanide Antidote Shortage

Category: Toxicology

Keywords: Cyanide, antidote, hydroxycobalmin, drug shortage (PubMed Search)

Posted: 11/5/2025 by Kathy Prybys, MD (Updated: 12/4/2025)
Click here to contact Kathy Prybys, MD

Cyanide is one of the deadliest known poisons causing immediate toxic effects and lethality within seconds to minutes. Exposures are rare, most commonly by inhalational route (HCN gas) from structural fires due to combustion of synthetic materials or from ingestion of cyanide salts. Cyanide toxicity can also occur from dermal or parental (sodium nitroprusside) exposure. 

  • Cyanide is a mitochondrial poison act by binding the heme portion of cytochrome oxidase a3 in the electron transport chain halting ATP production from oxygen shifting cellular respiration from aerobic to anaerobic metabolism causing a profound lactic acidosis > 8
  •  Impaired peripheral oxygen delivery and utilization can cause “arterialization” of venous blood (cherry red skin), in which the concentration of venous oxygen resembles that of arterial blood 
  • Clinical effects are profound but nonspecific, most frequently reported include unresponsiveness, respiratory failure, hypotension, cardiac arrest, and seizure
  • There are no pathognomonic clinical symptoms or diagnostic blood tests for cyanide poisoning (good correlation of carboxyhemoglobin levels >10 with cyanide toxicity, lactate level >10), clinical suspicion is required
  • Rapid administration of antidote is crucial. Survival is determined by timing of exposure, rapid recognition, and administration of antidote and supportive treatment. 

The preferred first line antidote is hydroxycobalamin (vitamin B12) available as Cyanokit, which has higher affinity for cyanide than cytochrome oxidase and binds to form harmless cyanocobalamin and is renally excreted. Limited studies reveal good survival rates in noncardiac arrest patients. Hydroxycobalamin has minimal side effects (red skin and urine, increased BP) and is well-tolerated with safer and simpler mechanism of action than Nithiodote (original antidote), containing sodium nitrite (CN preferentially binds methemoglobin to form cyanomethemoglobin) and thiosulfate (provides sulfur to convert cyanide to thiocynate for excretion). Sodium nitrite has numerous adverse effects causing hypotension and methemoglobin (contraindicated in smoke inhalation victims due to concern for carbon monoxide poisoning, G6PD deficiency, preexisting amenia), and hypersensitivity reactions. Sodium thiosulfate has less side effects and augments cyanide excretion but is considered less effective due to its slow onset, short half-life, low volume of distribution, and poor intracellular penetration.  

As of August 2025, the American Society of Health -System Pharmacists (ASHP) Drug Shortage lists Cyanokit as “limited availability” in the U.S. as manufacturing was suspended due to investigation of ongoing quality defect with concern for sterility and endotoxin content. Impacted batches were released and their numbers are listed in an FDA bulletin (see references). Healthcare providers should weigh the potential benefit of using Cyanokit against the risk of infection. Infusion set with 0.2 micron in line filter can be temporarily used for administration of Cyanokit 5 mg hydroxycobalmin to prevent potential infection.

Show References



Title: CO Pulse Oximetry in CO Poisoning

Category: Toxicology

Keywords: Carbon Monoxide, Hyperbaric (PubMed Search)

Posted: 9/26/2025 by TJ Gregory, MD (Updated: 9/29/2025)
Click here to contact TJ Gregory, MD

Carbon Monoxide Poisoning (COP) is a major toxicologic pathology and a common case in the Emergency Department and pre-hospital setting. History is a key component in assessment with the standard diagnostic test being blood gas analysis of Carboxyhemoglobin (COHb). 

Standard pulse oximeter devices are not capable of differentiating oxyhemoglobin from carboxyhemoglobin, leading to the classic pearl that pulse ox may be falsely reassuring in COP. 

In recent years, devices capable of differentiating oxyhemoglobin from COHb have been developed and are fielded in many hospitals and EMS agencies. 

This meta-analysis reviews diagnostic accuracy of pulse CO-oximetry (spCO) devices in comparison to a reference standard COHb blood test. Six studies (1734 patients) were included.

This analysis found that spCO testing has a low sensitivity and high specificity

Pooled sensitivity 0.65 (95% CI 0.44–0.81) 

Pooled specificity 0.93 (95% CI 0.83–0.98)

Pooled LR+ 9.4 (95% CI 4.4 to 20.1)

Pooled LR- 0.38 (95% CI 0.24 to 0.62)

The authors conclude that the low sensitivity precludes use of spCO as an effective screening tool for COP or substitute for COHb. Conversely, we can recognize the utility of the high specificity in identifying patients who do have clinically significant toxicity.  Indeed, the authors discuss potential applications for triage and transport to a hyperbaric oxygen chamber for those who are found to have elevated readings.

Technology advancement and refinement will be interesting to follow. In the meantime, don’t skip the COHb lab just because spCO measurement is reassuring.

Show References



Title: Phenobarbital order set implementation for alcohol withdrawal

Category: Toxicology

Keywords: alcohol withdrawal, phenobarbital, protocol, implimentation (PubMed Search)

Posted: 9/24/2025 by Robert Flint, MD (Updated: 9/25/2025)
Click here to contact Robert Flint, MD

This study looking at pre and post-phenobarbital order set use to treat inpatient alcohol withdrawal syndrome found:

“AWS symptoms resolved more rapidly after implementation, with a 4.2- to 5.0-point reduction in daily maximum CIWA-Ar scores at 24 to 96 hours from hospital presentation, 30.1-hour reduction in AWS treatment duration (95% CI, 16.7-43.5 hours), and 2.2-day reduction in time to hospital discharge (95% CI, 0.7-3.7 days). Safety outcomes did not significantly differ before and after implementation.”

Remember phenobarbital can be used for alcohol withdrawal for our ED patients as well. 

Here is the protocol:

Nursing

Vital signs 10 minutes after phenobarbital loading dose

Clinical Institute Withdrawal Assessment for Alcohol Revised (CIWA-Ar) every 1-4 hours based on score

Loading Dose

Phenobarbital 15 mg/kg intravenous piggyback (recommended for most patients)

Phenobarbital 10 mg/kg intravenous piggyback (low risk or heavily pretreated with benzodiazepines)

As-Needed Doses

Phenobarbital 130 mg intravenous twice as needed for uncontrolled agitation or CIWA-Ar ?15

Phenobarbital 260 mg intravenous once as needed for uncontrolled agitation or CIWA-Ar ?15

Show References



Title: Is it cocaine, fentanyl or amphetamine? Yes.

Category: Toxicology

Keywords: Toxicology, contaminate, opiate, stimulant (PubMed Search)

Posted: 4/5/2025 by Robert Flint, MD (Updated: 12/4/2025)
Click here to contact Robert Flint, MD

This study from Australia reminds us that what patients think they ingested isn’t always what they did ingest. A high percentage of “cocaine” and other stimulants was actually fentanyl or other opiates. The authors do  a nice job referencing similar studies in the United States. Any overdose could be a mixed picture due to impure street drugs.

Show References



This retrospective population cohort study looked at  first time ED visits for adolescents and young adults comparing those with visits related to alcohol to those not related to alcohol. Patients in the alcohol related visit group had  a threefold increased one year mortality rate.  Cause of death was trauma, poisoning by drug and alcohol. Risk factors include being male, age 20-29, history of mental health and having a visit for withdrawal.  

Adolescents and young adults presenting to an emergency department for an alcohol related complaint are high risk for one year mortality and deserve intervention and appropriate referral.

Show References



Title: QRS widening from Bupropion and NaHCO3 administration

Category: Toxicology

Keywords: bupropion, QRS widening, NaHCO3 (PubMed Search)

Posted: 2/15/2024 by Hong Kim, MD (Updated: 12/4/2025)
Click here to contact Hong Kim, MD

Bupropion associated cardiac toxicity widens the QRS complex by inhibiting the cardiac gap junction, not cardiac Na channel blockade. NaHCO3 is often administered when EKG changes are noted. But the effectiveness of NaHCO3 in bupropion toxicity is not well established. 

A retrospective study between 2010-2020 showed, that administration of NaHCO3 only decreased QRS duration by 2 msec (median). The median NaHCO3 administered was 100 mEq. Although this study was limited by the fact that it only had a small sample size of 13, NaHCO3 administration may provide limited clinical benefit in patients with QRS widening from bupropion overdose.

Show References



Title: Fomepizole for acetaminophen overdose?

Category: Toxicology

Keywords: acetaminophen overdose, fomepizole, NAC (PubMed Search)

Posted: 7/19/2023 by Natasha Tobarran, DO (Updated: 12/4/2025)
Click here to contact Natasha Tobarran, DO

Acetaminophen (APAP) is the leading cause of acute liver failure worldwide. Standard treatment for APAP overdose is with N-acetylcysteine (NAC), which is highly effective if given within 8 hours of ingestion.  However, in delayed presenters or massive ingestions patients can still develop hepatotoxicity. Adjunctive therapies can be considered in these cases including augmented NAC dosing, renal replacement, and fomepizole.

A small amount of APAP is metabolized to N-acetyl-p-benzoquinone imine (NAPQI) by cytochrome 2E1. In therapeutic doses, the body is able to detoxify the NAPQI using glutathione. In overdose, glutathione stores get depleted and NAPQI can cause hepatotoxicity. Mitochondrial damage in APAP overdose is mediated by the c-Jun-N-terminal Kinase (JNK) pathway. 

NAC works to replenish glutathione stores and detoxify NAPQI. In large overdoses, increased dosing of NAC may be necessary. Fomepizole is typically used for its alcohol dehydrogenase inhibitor property to treat methanol and ethylene glycol poisoning. Fomepizole is also a cytochrome 2E1 and JNK inhibitor and can be used in APAP overdose to block the formation of NAPQI and mitigate mitochondrial damage.  Dialysis can be used to eliminate APAP from the body completely in massive overdoses or if significant acidosis or renal failure. 

This study is a case series of 14 patients treated for APAP overdose between 2017 – 2021 at a tertiary hospital

  • Patients treated with standard NAC therapy
  • They also received IV fompeizole loading dose of 15 mg/kg followed by 10mg/kg every 12 hours at the discretion of the treating team
  • Most cases received only the loading dose
  • Some cases also received renal replacement therapies
  • Patients had “better than expected outcomes” based on initial presentation, APAP levels, liver function tests, and expected clinical course
  • No unfavorable outcomes
  • No side effects

Limitations of the study:

  • Patients were treated with NAC which is the standard of care
  • No formal protocol for the administration or identification of patients treated with fompeizole

In summary:

  • NAC is the standard of care in acetaminophen poisonings
  • Consider fomepizole as an adjunctive therapy in patients that are critically ill
  • Consult your poison center 1-800-222-1222 or friendly toxicologist for help in identifying these patients

Show References



Age >36

LOC

Prolonged exposure (>24hrs)

COHgb level >25%

Show References



Title: Pediatric edible cannabis toxicity

Category: Toxicology

Keywords: cannabis exposure, pediatric, toxicity, NPDS (PubMed Search)

Posted: 7/6/2023 by Hong Kim, MD (Updated: 12/4/2025)
Click here to contact Hong Kim, MD

Medical Cannabis is permitted in 39 states and Washington DC while 18 sates and Washington DC has legalized recreational cannabis use. As cannabis products become more available, pediatric exposure has also increased.

A retrospective study of National Poison Data System involving children < 6 years from 2017 and 2021 showed: Pre-COVID (2017-2019) & COVID (2020-2021)

  • 7043 exposures: (increase of 1375%)
  • 2017: 207  
  • 2021: 3054 
  • Residential exposure: 97% (n=6842)

Common Clinical effects

  • CNS depression: 70% (n=3381)
    • Pre-COVID: 61.6% --> COVID: 72.9% (p<0.05)
  • Tachycardia: 11.4% (N=548)
    • Pre-COVID: 10.3% -->COVID: 11.6% (p,0.05)
  • Vomiting: 9.5% (n=4827)
    • Pre-COVID: 7.5% -->COVID: 10.0% (p<0.05)
  • Ataxia: 7.4% (n=352)
  • Confusion: 6.1% (n=294)
  • Mydriasis: 5.9% (n=284)
  • Respiratory depression: 3.1%

Disposition

  • Admission: 22.7%
  • Critical care: 8.1% (n=533)
    • Pre-COVID: 6.6% -->COVID: 8.6% (increase of 30%) (p<0.05)
  • Non-critical care: 14.6% (n=1027)
    • Pre-COVID: 9.7% -->COVID: 16.3% (increase of 68%)(p<0.05)

Conclusion

  • Pediatric cannabis exposure has increased between 2017 and 2021. consequently, more pediatrics patients developing toxicity and being hospitalized.

Show References



Title: Falsely Elevated Lithium Levels

Category: Toxicology

Keywords: Lithium, Lab error, Toxicity (PubMed Search)

Posted: 6/15/2023 by Natasha Tobarran, DO (Updated: 12/4/2025)
Click here to contact Natasha Tobarran, DO

Lithium toxicity can present acutely with gastrointestinal symptoms and chronically with neurologic symptoms such as tremor and ataxia. Diagnosis and treatment with normal saline hydration and/or dialysis depends on lithium levels in conjunction with signs and symptoms.

Lithium levels can be falsely elevated when blood samples are collected in green top tubes which contain lithium heparin, or if the blood collection volume is too small.  Not recognizing that a lithium level may be falsely elevated can lead to misdiagnosis as well as unnecessary hospitalizations and treatments. The study by Wills et al found lithium levels as high as 4 mmol/L (therapeutic range 0.6-1.2 mmol/L) in lithium naïve volunteers collected in the wrong tube and with small blood volumes. If a patient has an elevated lithium level in the absence of lithium toxicity symptoms, consider a falsely elevated level and redraw using the appropriate tube and sample size. 

In summary:

  • Ensure the lithium sample is collected in a non heparin containing tube
  • Confirm sufficient sample volume
  • Look at the clinical picture when deciding on treatment for patient
  • Have a low threshold to repeat the lithium level
  • Consult your poison center 1-800-222-1222 or friendly toxicologist

Show References



Title: High dose insulin for calcium channel blockers: amlodipine vs. non-dihydropyridines

Category: Toxicology

Keywords: amlodipine, non-dihydropyridines, high-dose insulin (PubMed Search)

Posted: 6/1/2023 by Hong Kim, MD (Updated: 12/4/2025)
Click here to contact Hong Kim, MD

Calcium channel blocker (CCB) overdose can lead to severe shock/hypotension. A small study was conducted to compare the hemodynamic effects of high-dose insulin (HDI) for two classes of CCB (dihydropyridines vs. non-dihydropyridines) that work differently to manage hypertension.   

Study design:

  • Retrospective study from a single poison center (2019 – 2021)

Study sample:

  • Amlodipine poisoning cases: 18
  • Non-dihydropyridine (non-DHP) poisoning cases: 15

Result

Median number of maximum concomitant vasopressors (p=0.04)

  • Amlodipine: 3 (IQR: 2-5; range 0-6)
  • Non-DHP: 2 (IQR: 1-3; range 0-5)

Median difference in max concomitant vasopressors: 1 (95% CI: 0 – 2)

Median max epinephrine dosing

  • Amlodipine: 0.31 mcg/kg/min
  • Non-DHP: 0.09 mcg/kg/min

Use of rescue methylene blue (p=0.009)

  • Amlodipine: 7/18 (39%)
  • Non-DHP: 0

Conclusion:

  • Amlodipine poisoning on HDI required more vasopressors and higher doses of epinephrine compared to non-DHP (verapamil or diltiazem)
  • This may be due to vasodilatory effect of amlodipine compared to non-DHPs

Show References



 

Flumazenil is a reversal agent for benzodiazepine overdose.  Adverse events including seizure, agitation and cardiac arrhythmias have been reported but the frequency of adverse events is unknown.

AE and serious AEs were defined as:

AE: 

  • Aggressive behavior, agitation, screaming, restlessness
  • Nausea/vomiting, abdominal cramps
  • Sweating, shivering, chills, hot flashes
  • Headache, dizziness
  • Anxiety, distress, depressed mood, abnormal crying
  • Tremors 

Serious AE (SAE):

  • Seizures
  • Supraventricular arrhythmia
  • Multiple ventricular beats
  • Tachycardia
  • Sudden fall in systolic BP

A systematic review/meta-analyses of 13 randomized controlled trials showed

  • AEs more common in flumazenil group vs. placebo (risk ratio: 2.85; 95% CI: 2.11-3.84)
  • SAEs more common in flumazenil group vs. placebo (risk ratio: 3.81; 95% CI: 1.28-11.39) 

Most common AEs

  • Aggressive behavior, agitation, screaming: 26.2% (n=33/126)
  • Nausea/vomiting, abdominal cramps: 20.6% (n=26/126)
  • Anxiety, distress, depressed mood: 15.7% (n=19/126)

Most common SAEs

  • Supraventricular arrhythmia: 30% (n=4/12)
  • Seizure: 25% (n=3/12)
  • Tachycardia: 25% (n=3/12)

Conclusion

  • Administration of flumazenil to patients with known or suspected benzodiazepine overdose is associated with increased risk of AEs

Show References



Title: Xylazine in heroin/fentanyl

Category: Toxicology

Keywords: xylazine, adulterate, heroin, fentanyl (PubMed Search)

Posted: 12/16/2021 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Xylazine is a central alpha-2 agonist (similar to clonidine) that is used as a veterinary tranquilizer. It also possesses analgesic, and muscle relaxant properties. Heroin/fentanyl is increasingly being adulterated with xylazine and resulting in severe adverse effects (CNS and respiratory depression, bradycardia, and hypotension), including deaths. 

According to CDC, 0.1%-5.5% of IMF death in US between 2019 – 2020 involved xylazine. 

In Philadelphia, PA:

The detection of xylazine in unintentional overdose death increased from

  • 2010 – 2015: 2%
  • 2016: 11%
  • 2017: 10%
  • 2018: 18%
  • 2019: 31%

Approximately 25% of drug seizures in Philadelphia contained xylazine in 2019

 

There is no effective pharmacologic agent for xylazine toxicity. Similar to clonidine toxicity, high dose naloxone may be tried. But pediatric data show that approximately 50% of pediatric clonidine toxicity response to high-dose naloxone administration. Thus, naloxone administration may not reverse the CNS/respiratory depression, bradycardia and hypotension.

 

Conclusion

  • There is increasing adulteration of heroin/fentanyl with xylazine
  • Naloxone administration may not reverse the toxicity of xylazine

Show References



 

Substance use disorder contributes significantly to pediatric exposure/poisoning. There has been an increase in the opioid overdose deaths in the US, placing pediatric population to possible exposure. A retrospective study of fatal pediatric poisoning in the US was investigated using the National Violent Death Reporting System (NVDRS) from 2012-2017.

17 US states (AK, CO, GA, KT, MD, MA, NJ, NM, NC, OH, OK, OR, RI, SC, UT, VA, WI) reported to NVDRS from 2012-2017.   

Age was limited to 0-9 years

 

Results

1850 violent deaths were identified: n=122 (7%) were poisoning related

 

Characteristics

  • Male: 49%
  • Approximately 25% were homicide-suicides

Region

  • Midwest: 25%
  • Northeast: 5%
  • South: 53%
  • West: 17%

Most common exposure/etiology

  1. Opioid (50%)
  2. Benzodiazepines (8%)
  3. Amphetamines (7%)
  4. Antidepressants (5%)

Conclusion

  • A large proportion of poisoning related pediatric fatality was due to opioid exposure
  • Largest proportion of death was reported from the Southern US.

Show References



Title: Clinical severity score for acute poisoned patients ICU requirement score (IRS)

Category: Toxicology

Keywords: ICU requirement score, physiologic score system (PubMed Search)

Posted: 8/19/2021 by Hong Kim, MD (Updated: 8/20/2021)
Click here to contact Hong Kim, MD

 

There are several clinical scoring systems (SAPS II, SAPS III, SOFA, etc.) to assess the severity and/or risk of mortality in critically ill patients. However, the routinely used physiologic scoring systems are not always suitable for poisoned patient. 

ICU requirement score (IRS) has been recently developed by investigators from Europe and a validation study (retrospective cohort) has been performed.

ICU requirement score (IRS) components (see inserted table)

  • Age
  • Systolic blood pressure
  • Heart rate
  • GCS
  • Type of intoxication
  • Comorbidities (dysrhythmia, cirrhosis, and/or respiratory insufficiency, secondary diagnosis requiring ICU admission)

Retrospective cohort 

  • Study duration: Jan 1, 2009 to Dec 31 ,2019
  • Positive IRS score: >= 6
  • Comparison to SAPS II, SAPS III, SOFA score, and PSS
  • End point: need for ICU treatment

Results

N=1503

Area under the curve for IRS ROC: 0.736 (95% CI: 0.702-0.770)

IRS <6

  • Negative predictive value: 95% (95% CI: 93-97)
  • Positive predictive value: 21% (95% CI: 18-24)
  • Sensitivity: 89% (95% CI: 85-93)
  • Specificity: 38% (95% CI:36-41)

Conclusion

  • IRS of < 6 demonstrated excellent negative predictive value for ICU admission.
  • A larger study of ICU requirement score will be needed to further assess its usefulness/limitation prior to clinical use.  

Show References

Attachments



Title: Pediatric cannabis exposure before and after legalization in Canada

Category: Toxicology

Keywords: cannabis intoxication, trend, Canada, ICU admission, legalization (PubMed Search)

Posted: 7/8/2021 by Hong Kim, MD
Click here to contact Hong Kim, MD

 

Canada legalized recreational cannabis use in 2017. A retrospective study of children (0-18 years) who presented to pediatric ED with cannabis intoxication/exposure was performed between Jan 1, 2008 to Dec 21, 2019 to assess the trend/severity of intoxication.

Methods

  • Single center study: Hospital for Sick Children, Toronto
  • Case identification by ICD 10 code for cannabis intoxication and positive urine drug screening test
  • Pre-legalization period was defined as 1/1/2008 to 4/12/2017
  • Peri-post legalization period was defined as 4/13/2017 to 12/31/2019

 

Result

A total of 298 patients were identified

  • Pre-legalization period: 232 (77.8%)
  • Peri-post legalization period: 66 (22.1%)
  • Male: 150 (50.3%)
  • Median age: 15.9 years (IQR: 15.0-16.8) 

 

Pre-legalization

Peri-post legalization

P value

Monthly ED visit

2.1 (IRQ: 1.9-2.5)

1.7 (IQR: 1.0-3.0)

0.69

ICU admission

4.7%

13.6%

0.02

Respiratory symptoms

50.9%

65.9%

0.05

Altered mental status

14.2%

28.8%

<0.01

Age < 12 years

3.0%

12.1%

0.04

Unintentional exposure

2.8%

14.4%

0.02

Edible ingestion

7.8%

19.7%

0.02

Respiratory symptoms: tachypnea/bradypnea, cyanosis, O2 sat < 92%, bronchospasm, oxygen requirement

  • Edible ingestion was a predictor of ICU admission (OR: 4.1; 95% CI: 1.2-13.7)

 

Conclusion

  • Legalization of recreational cannabis in Canada was associated with increased rates of severe intoxication in children.

Show References



Question

 

What is the mechanism of action of N-acetylcysteine that is used to treat acetaminophen induced liver injury/toxicity?

 

 

 

 

 

 

 

 

Show Answer

Show References



Title: Getting "high" on household spices.

Category: Toxicology

Keywords: household spices, abuse, toxicity (PubMed Search)

Posted: 4/8/2021 by Hong Kim, MD (Updated: 12/4/2025)
Click here to contact Hong Kim, MD

 

There are three commonly household spices that can be abuse/misused or cause toxicity after exposure.

Pure vanilla extract contains at least 35% ethanol by volume per US Food and Drug Administration standards

  • Results in alcohol intoxication
  • Ingestion of 1.3 mL/kg in child will result in blood ethanol concentration of 100 mg/dL

 

Nutmeg contains myristicin – serotonergic agonist that possess psychomimetic properties. 

  • Typical recreational dose: 5-30 gm. (tablespoon of ground nutmeg: 7 gm).

Clinical effects:

  • GI symptoms: nausea, vomiting and abdominal pain
  • Cardiovascular: hypertension and tachycardia
  • CNS: hallucination, paranoia, seizure
  • Others: flushing, mydriasis

 

Cinnamon contains cinnamaldehyde and eugenol – local irritants.

  • Can cause contact dermatitis and ulceration from topical application
  • Inhalation of cinnamon can result in chronic and significant pulmonary inflammation and fibrosis

Show References



 

Diphenhydramine is commonly involved in overdose or misused. Although it is primarily used for its anti-histamine property, it also has significant antimuscarinic effect.

A recent retrospective study investigated the clinical characteristics associated with severe outcomes in diphenhydramine overdose using the multi-center Toxicology Investigators Consortium (ToxIC) Registry. 

Severe outcomes were defined as any of the following:

  • Seizure
  • Ventricular dysrhythmia
  • Intubation

 

Results

863 cases of isolated diphenhydramine ingestion were identified between Jan 1, 2010 to Dec 31, 2016

  • Females: 59.1% 
  • Age < 18 years: 51.3%
  • Intentional ingestion: 86.0%
    • Self-harm: 37.5%
    • Abuse/misuse: 11.5%

Most common symptoms:

  • Delirium/toxic psychosis: 40.1% (n=346)
  • Agitation: 33.1% (n=286)
  • Severe outcome: 15.6% (n=135)

Factors associated with severe outcome

  • Intubation: self-harm ingestion and male
  • Acidemia: pH <7.2
  • QRS prolongation: QRS > 120 msec
  • Elevated anion gap: AG >20

Conclusion

  • Acidemia, QRS prolongation and elevated anion gap was associated with severe outcome in diphenhydramine toxicity

Show References